# Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients

> **NCT05682911** · EARLY_PHASE1 · COMPLETED · sponsor: **Jinnah Sindh Medical University** · enrollment: 40 (actual)

## Conditions studied

- The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients

## Interventions

- **DRUG:** Zingiber officinale L. tablets
- **DRUG:** Simvastatin 20mg

## Key facts

- **NCT ID:** NCT05682911
- **Lead sponsor:** Jinnah Sindh Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2018-06-02
- **Final completion:** 2018-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05682911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05682911, "Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05682911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*